Kasvu Therapeutics
Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs.
€30MSeries A
ParticipantActivity from announced rounds
Stephen Industries is the corporate investor named by AlixLabs and in Kasvu financing coverage.
AlixLabs develops semiconductor etching processes. Kasvu develops non-hallucinogenic neuroplasticity treatments, while Anferra recycles steel waste. The records retain distinct technologies and keep unpublished participation in draft.
Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs.
AlixLabs develops atomic-layer etching processes and equipment for semiconductor manufacturers making smaller, more densely packed chip features.